| Primary |
| Ovarian Cancer |
42.0% |
| Premedication |
12.4% |
| Product Used For Unknown Indication |
11.9% |
| Hypertension |
4.4% |
| Infection |
4.4% |
| Ovarian Cancer Recurrent |
4.4% |
| Ovarian Cancer Metastatic |
3.1% |
| Depression |
2.7% |
| Adenocarcinoma |
1.8% |
| Hypothyroidism |
1.8% |
| Prophylaxis Of Nausea And Vomiting |
1.8% |
| Sarcoma |
1.8% |
| Antiemetic Supportive Care |
1.3% |
| Blood Calcium Decreased |
0.9% |
| Breast Cancer |
0.9% |
| Chemotherapy |
0.9% |
| Diabetes Mellitus |
0.9% |
| Hypercholesterolaemia |
0.9% |
| Leiomyosarcoma |
0.9% |
| Neoplasm Malignant |
0.9% |
|
| Pancytopenia |
19.0% |
| Urinary Tract Infection |
12.1% |
| Renal Failure Acute |
10.3% |
| Vomiting |
10.3% |
| Phlebitis |
6.9% |
| Respiratory Failure |
5.2% |
| Cognitive Disorder |
3.4% |
| Diarrhoea |
3.4% |
| Febrile Neutropenia |
3.4% |
| Neutrophil Count Decreased |
3.4% |
| Palpitations |
3.4% |
| Pyrexia |
3.4% |
| Rhabdomyolysis |
3.4% |
| Acute Myocardial Infarction |
1.7% |
| Anaemia |
1.7% |
| Aspartate Aminotransferase Increased |
1.7% |
| Asthenia |
1.7% |
| Atrial Fibrillation |
1.7% |
| Cardiac Failure |
1.7% |
| Cardiac Failure Congestive |
1.7% |
|
| Secondary |
| Ovarian Cancer |
29.9% |
| Premedication |
15.9% |
| Hypertension |
9.2% |
| Product Used For Unknown Indication |
5.9% |
| Chemotherapy |
5.4% |
| Sarcoma |
4.3% |
| Depression |
3.8% |
| Liposarcoma |
3.5% |
| Hypothyroidism |
3.0% |
| Adenocarcinoma |
2.2% |
| Blood Calcium Decreased |
2.2% |
| Diabetes Mellitus |
2.2% |
| Hypercholesterolaemia |
2.2% |
| Oedema Due To Cardiac Disease |
2.2% |
| Platelet Aggregation Inhibition |
2.2% |
| Prophylaxis Of Nausea And Vomiting |
1.9% |
| Ovarian Cancer Recurrent |
1.3% |
| Leiomyosarcoma |
1.1% |
| Ovarian Cancer Metastatic |
1.1% |
| Antiemetic Supportive Care |
0.8% |
|
| Phlebitis |
18.8% |
| Pancytopenia |
8.2% |
| Vomiting |
8.2% |
| Blood Creatine Phosphokinase Increased |
7.1% |
| Hypoalbuminaemia |
7.1% |
| Neutropenia |
7.1% |
| Urinary Tract Infection |
7.1% |
| Renal Failure Acute |
5.9% |
| Acute Myocardial Infarction |
4.7% |
| Cardiac Failure |
4.7% |
| Malaise |
3.5% |
| Rhabdomyolysis |
3.5% |
| Cognitive Disorder |
2.4% |
| Diarrhoea |
2.4% |
| Neutrophil Count Decreased |
2.4% |
| Palpitations |
2.4% |
| Aspartate Aminotransferase Increased |
1.2% |
| Asthenia |
1.2% |
| Cardiac Failure Congestive |
1.2% |
| Febrile Neutropenia |
1.2% |
|
| Concomitant |
| Product Used For Unknown Indication |
36.8% |
| Ovarian Cancer |
31.6% |
| Synovial Sarcoma |
21.1% |
| Breast Cancer Metastatic |
10.5% |
|
| Fanconi Syndrome |
25.0% |
| Lung Infection |
25.0% |
| Sepsis |
25.0% |
| Tachycardia |
25.0% |
|
